This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Patient-derived xenograft models of rare estrogen receptor-positive ovarian cancers
Molecular and Functional Characterization of a Patient-Derived Organoid Platform for Ovarian Cancer
Exploring a new therapeutic approach for rare ovarian cancers
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response
Investigating the “surfaceome” to discover new treatments for rare ovarian cancers
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses
Metabolic engineering of CAR-T cells to overcome immune suppression
Optimizing an off-the shelf ovarian cancer RNA vaccine
Fallopian imaging and lavage for early-stage tubo-ovarian cancer detection